Literature DB >> 2180835

Metabolic problems after gastric surgery.

E Harju1.   

Abstract

The findings on dumping syndrome (DS) are not consistent considering its relations with age, sex, weight/height, smoking habits, race, dose of oral glucose, the time elapsed since surgery, the function of exocrine pancreas nor the duration of ulcer symptoms. The patients after total gastrectomy (TG) may present relative postprandial lack of insulin. As a sign of long-term hyperglycemia elevated HbA1 has been measured in DS patients. Oral galactose test may reveal new features of DS. Abnormalities in splanchnic blood circulation as well as release of intestinal hormones are involved with DS. Dietary habits including fibers, pectin and guar gum, play a central role in the prevention and treatment of DS. In unresponsive cases several operative methods have been applied with success. Alkaline reflux gastritis is most often seen after B II and I reconstructions and after pyloroplasty. Chronic diarrhea follows mostly after truncal vagotomy. Ten to 50% of patients after gastrectomy (GE) waste 10 to 20% of their body weight because of decreased food, energy, vitamin and mineral intake caused by eating-related symptoms. Vitamin and mineral supplements, a small snack 20 min before the major meal, digestive enzymes, treatment of colonization with antibiotics and protein foods may help. About 50% of GE patients show iron deficiency anemia. Easily dissolved iron between meals with ascorbic acid give the most effective response. Deficiency of vitamin B12 or of folate may develop as megaloblastic anemia. B12 supplement and antibiotics are effective in bacterial overgrowth, but surgical correction is necessary in troublesome blind loop. Folic acid deficiency is corrected by oral folic acid.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1990        PMID: 2180835

Source DB:  PubMed          Journal:  Int Surg        ISSN: 0020-8868


  6 in total

1.  Characteristics and clinical relevance of postgastrectomy syndrome assessment scale (PGSAS)-45: newly developed integrated questionnaires for assessment of living status and quality of life in postgastrectomy patients.

Authors:  Koji Nakada; Masami Ikeda; Masazumi Takahashi; Shinichi Kinami; Masashi Yoshida; Yoshikazu Uenosono; Yoshiyuki Kawashima; Atsushi Oshio; Yoshimi Suzukamo; Masanori Terashima; Yasuhiro Kodera
Journal:  Gastric Cancer       Date:  2014-02-11       Impact factor: 7.370

2.  Enteral vitamin B12 supplements reverse postgastrectomy B12 deficiency.

Authors:  S Adachi; T Kawamoto; M Otsuka; T Todoroki; K Fukao
Journal:  Ann Surg       Date:  2000-08       Impact factor: 12.969

3.  Anemia after gastrectomy for early gastric cancer: long-term follow-up observational study.

Authors:  Chul-Hyun Lim; Sang Woo Kim; Won Chul Kim; Jin Soo Kim; Yu Kyung Cho; Jae Myung Park; In Seok Lee; Myung-Gyu Choi; Kyo-Young Song; Hae Myung Jeon; Cho-Hyun Park
Journal:  World J Gastroenterol       Date:  2012-11-14       Impact factor: 5.742

4.  Factors affecting the quality of life of patients after gastrectomy as assessed using the newly developed PGSAS-45 scale: A nationwide multi-institutional study.

Authors:  Koji Nakada; Masazumi Takahashi; Masami Ikeda; Shinichi Kinami; Masashi Yoshida; Yoshikazu Uenosono; Yoshiyuki Kawashima; Sayumi Nakao; Atsushi Oshio; Yoshimi Suzukamo; Masanori Terashima; Yasuhiro Kodera
Journal:  World J Gastroenterol       Date:  2016-10-28       Impact factor: 5.742

5.  Pancreatic enzyme supplementation after gastrectomy for gastric cancer: a randomized controlled trial.

Authors:  Marco Catarci; Manuele Berlanda; Giovanni Battista Grassi; Francesco Masedu; Stefano Guadagni
Journal:  Gastric Cancer       Date:  2017-08-14       Impact factor: 7.370

6.  Defecation disorders are crucial sequelae that impairs the quality of life of patients after conventional gastrectomy.

Authors:  Koji Nakada; Masami Ikeda; Masazumi Takahashi; Shinichi Kinami; Masashi Yoshida; Yoshikazu Uenosono; Masanori Terashima; Atsushi Oshio; Yasuhiro Kodera
Journal:  World J Gastrointest Surg       Date:  2021-11-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.